Top Story

Clinical setbacks integral to long-term success in HCV treatment

December 19, 2014

In a new report, the Pharmaceutical Research and Manufacturers of America examined the successes and failures of hepatitis C virus infection research and therapies since the infection was discovered 25 years ago.

“Hepatitis C research successes have built over time,” the report said. “Following the identification of the virus in 1989, stepwise improvements in interferon-based therapy ensued over the next two decades…After years of research and many setbacks, the first of these medicines — direct-acting antivirals — were approved in 2011. Since that time, many more of these medicines have been approved and researchers are finding even greater success in employing a combination of antiviral therapies to more effectively combat the disease.”

In the Journals

Cryptosporidiosis outbreak linked to calves involved in rollover accident

December 19, 2014
An outbreak of six cases of cryptosporidiosis was identified among emergency responders to a rollover accident involving a tractor-trailer carrying approximately 350…

CMS releases new quality of care data on physicians, ACOs, hospitals

December 19, 2014
CMS released new data on the quality of care provided by physician group practices, hospitals and Accountable Care Organizations, according to the CMS Blog.Included in…

CDC, FDA: Multistate listeriosis outbreak linked to caramel apples

December 19, 2014
The CDC and FDA announced an ongoing investigation of an outbreak of listeria infections associated with commercially produced, prepackaged caramel apples.As of Dec. 18…

Patients with complicated intra-abdominal infections achieved clinical response with eravacycline

December 19, 2014
Positive preliminary results from the phase 3 IGNITE 1 trial indicate that eravacycline is non-inferior to ertapenem in achieving clinical response in patients with…
More News Headlines »
CME CNE CPE Video
Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

This activity is supported by an educational grant from Bristol-Myers Squibb.

Protease inhibitors (PIs) have played an instrumental role in decreasing mortality andmorbidity among HIV-infected…
More »
Meeting News Coverage Video
thumbnail for video 3911388507001

Student education, immunization requirements necessary to prevent outbreaks on college campuses

November 28, 2014
NEW YORK — James C. Turner, MD, executive director of the department of student health and the National Social…
More »
CME
j526

Regimen Selection in HIV: Considering New Options to Optimize Outcomes

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than two decades into the antiretroviral therapy (ART) era, there are numerous options for HIV treatment. The goal…
More »
morganatic-roan